Penn Medicine Provider
Steven S. Scherer, MD, PhD
4.9
(140)

About me

  • Vice Chair for Academic Development, Department of Neurology
  • Emeritus Professor of Neurology

Education and training

  • Medical School: University of Michigan
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: University of Pennsylvania School of Medicine

What my patients think about me

Average Rating
4.9

140 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
as a professional and as a person, no one compares to dr. scherer! i'm grateful to have had him as my neurologist for so many years. i have learned so much from him and i'm always excited about the next time i see him.
May 2024
5.0
5.0
i have seen dr scherer for many years. he knows my condition and is a specialist.
May 2024
5.0
5.0
he'll be missed
May 2024
5.0
5.0
he goes beyond his job to explain problems

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Scherer is a Penn Medicine physician.

Qualifications and experience

My research

163., Fridman, V., S. Sillau, G. Acsadi, C. Bacon, K. Dooley, J. Burns, J. Day, S. Feely, R.S. Finkel, T. Grider, L. Gutmann, D.N. Herrmann, C.A. Kirk, S.A. Knause, M. Laura, R.A. Lewis, J. Li, T.E. Lloyd, I. Moroni, F. Muntoni, E. Pagliano, C. Pisciotta, G. Piscosquito, S. Ramchandren, M. Saporta, R. Sadjadi, R.R. Shy, C.E. Siskind, C.J. Sumner, D. Walk, J. Wilcox, S.W. Yum, S. Züchner, S.S. Scherer, D. Pareyson, M.M. Reilly, M.E Shy A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores. , Neurology , 94: 2020,e884-e896


Motley, W.W., S. Züchner, and S.S. Scherer Isoform-specific loss of Dystonin causes hereditary motor and sensory neuropathy. , Neurol. Genet. , 6: 2020,e496


Scherer, S.S., K.A. Kleopa, and M.D. Benson Peripheral Neuropathies. , In: Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, 6th edition, : 2020,345-375


Sase S., A.A. Almad, C.A. Boecker, P. Guedes-Dias, J.J. Li, A. Takanohashi, A. Patel, T. McCaffrey, H. Patel, D. Sirdeshpande, J. Curiel, J.S.-H. Liu, Q. Padiath, E.L.F. Holzbaur, S.S. Scherer, A. Vanderver TUBB4A mutations results in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model. , eLife , 9: 2020,e52986


Cortese A., Y. Zhu, A.P. Rebelo, S. Negri, S. Courel, L. Abreu, C.J. Bacon, Y. Bai, D.M. Bis-Brewer, E. Bugiardini, E. Buglo, M.C. Danzi, S.M.E. Feely, A. Athanasiou-Fragkouli, N.A. Haridy, Inherited Neuropathy Consortium, R. Isasi, A. Khan, M. Laura, S. Magri, M. Pipis, C. Pisciotta, E. Powell, A.M. Rossor, P. Saveri, J.E. Sowden, S. Tozza, J. Vandrovcova, J. Dallman, E. Grignani, E. Marchioni, S.S. Scherer, B. Tang, Z. Lin, A. Al-Ajmi, R. Schule, M. Synofzik, T. Maisonobe, T. Stojkovic, M. Auer-Grumbach, M.A. Abdelhamed, S.A. Hamed, R. Zhang, F. Manganelli, L. Santoro, F. Taroni, D. Pareyson, H. Houlden, D.N. Herrmann, M.M. Reilly, M.E. Shy, R.G. Zhai, S. Züchner Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes. , Nat Genet. , 52: 2020,473-481


Li J.J., N. Sarute, E. Lancaster, G. Otkiran-Clare, B.M. Fagla, S.R. Ross, and S.S. Scherer A recessive Trim2 mutation causes an axonal neuropathy in mice. , Neurobiol. Dis. , 140: 2020,104845


Pareyson D., T. Stojkovic, M.M. Reilly, S. Leonard-Louis, M. Laura, J. Blake, Y. Parman, E. Battaloglu, M. Tazir, M. Bellatache, N. Bonello-Palot, M. Levy, S. Sacconi, R. Guimaraes-Costa, S. Attarian, P. Latour, G. Sole, A. Megarbane, R. Horvath, G. Ricci, B.O. Choi, A. Schenone, C. Gemelli, A. Geroldi, M. Sabatelli, M. Luigetti, L. Santoro, R. Manganelli, A. Quattrone, P. Valentino, T. Murakami, S.S. Scherer, L. Dankwa, M.E. Shy, C.J. Bacon, D.N. Herrmann, A. Zambon, I. Tramacere, C. Pisciotta, S. Magri, S.C. Previtali, A. Bolino A multicentre retrospective study of Charcot-Marie-Tooth disease type 4B (CMT4B) due to mutations in myotubularin-related proteins (MTMRs). , Ann Neurol. , 86: 2019,55-67


Phillips, J., Courel, S., Bis-Brewer, D., Rebelo, A., Bardakjian, T., Dankwa, L., Hamedani, A., Züchner, S., Scherer, S. POLG mutations presenting as CMT. , J. Periph. Nerv. Syst., 24: 2019,214-218


A. Horga, E. Bugiardini, A. Manole, F. Bremner, Z. Jaunmuktane, L. Dankwa, A.P. Rebelo, C.E. Woodward, I.P. Hargreaves, A. Cortese, A.M. Pittman, S. Brandner, J.M. Polke, R.D.S. Pitceathly, S. Züchner, M.G. Hanna, S.S. Scherer, H. Houlden, M.M. Reilly Autosomal dominant optic atrophy and cataract “plus” phenotype including axonal neuropathy. , Neurol. Genet., 5: 2019,e322


Dankwa, L., Richardson, J., Motley, W.W., Scavina, M., Bardakjian, T., Züchner, S., Scherer, S.S. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family. , Neuromusc Dis, 29: 2019,134-137


View all publications